Artificial Intelligence Based Multimodality Imaging: A New Frontier in Coronary Artery Disease Management

Front Cardiovasc Med

13 Ottobre Ott 2021 15 days ago
  • Guglielmo M, Baggiano A, Fusini L, Pontone G

Coronary artery disease (CAD) represents one of the most important causes of death around the world. Multimodality imaging plays a fundamental role in both diagnosis and risk stratification of acute and chronic CAD. For example, the role of Coronary Computed Tomography Angiography (CCTA) has become increasingly important to rule out CAD according to the latest guidelines. These changes and others will likely increase the request for appropriate imaging tests in the future. In this setting, artificial intelligence (AI) will play a pivotal role in echocardiography, CCTA, cardiac magnetic resonance and nuclear imaging, making multimodality imaging more efficient and reliable for clinicians, as well as more sustainable for healthcare systems. Furthermore, AI can assist clinicians in identifying early predictors of adverse outcome that human eyes cannot see in the fog of "big data." AI algorithms applied to multimodality imaging will play a fundamental role in the management of patients with suspected or established CAD. This study aims to provide a comprehensive overview of current and future AI applications to the field of multimodality imaging of ischemic heart disease.

Reference

Artificial Intelligence Based Multimodality Imaging: A New Frontier in Coronary Artery Disease Management. Maragna R, Giacari CM, Guglielmo M, Baggiano A, Fusini L, Guaricci AI, Rossi A, Rabbat M, Pontone G. Front Cardiovasc Med. 2021 Sep 22;8:736223. doi: 10.3389/fcvm.2021.73622

Go to PubMed